2025-03-09
Igitero cyo gutanga ibiyobyabwenge kuri kanseri Yibanda ku gutanga abakozi ba Trapepetic by'umwihariko selile za kanseri, kugabanya ibizamurora. Ubu buryo bukoresha ingamba zitandukanye, harimo nanoparticles, antibodims, no kugwa kwa seliji, kugirango bikureho ibiyobyabwenge no kugabanya ingaruka nziza kandi zitanga ubuvuzi busobanutse kandi bwihariye kandi bwihariye bwa kanseri yihariye kandi yihariye.
Kuvura kanseri byahindutse cyane, hamwe Igitero cyo gutanga ibiyobyabwenge kuri kanseri kugaragara nkingamba zitanga ikizere. Ubu buryo bugamije guhitamo gutanga ibiyobyabwenge mu kagari ka kanseri, kumara ingaruka zo kuvura mu buryo bwo kugabanya ibyangiritse ku ngingo nziza. Mu buryo butandukanye na chimiotherapie isanzwe, ikwirakwiza ibiyobyabwenge mu mubiri, itangwa rigamije gukoresha uburyo butandukanye bwo gukemura neza kanseri.
Umutebe uduce gakondo akenshi uviramo ingaruka zikomeye kuko zigira ingaruka kumurongo wa kanseri kandi nzima. Igitero cyo gutanga ibiyobyabwenge kuri kanseri itanga igisubizo mugutanga ibiyobyabwenge kurubuga. Ibi bigabanya uburozi bwa sisitemu, biteza imbere imiti, kandi birashoboka ko ubuzima bwiza bwihangana.
Ingamba nyinshi zihanganye zikoreshwa muri Igitero cyo gutanga ibiyobyabwenge kuri kanseri, buri kimwe hamwe nibyiza byacyo nuburyo bugarukira.
Nanoparticles ni uduce duto (1-100 nm) rwagenewe gushinga no gutanga ibiyobyabwenge muri kanseri. Bashobora gutegurwa kugirango bayobore reseptors yihariye kurugingo rwa kanseri, nka egfr cyangwa hel2. Liposomes, Polymeric Nanoparticles, na Nanoparticles ya inzwi ikunze gukoreshwa. Ingaruka zongerewe no kugumana (EPR) zituma Nanoparticles kugirango irimbure mubyifuzo byigituba kubera imiyoboro ya lekculature.
Urugero: DOXILI, LIporubicicic, ni nanapicle ishingiye ku bucuruzi ishingiye ku bucuruzi yakoreshejwe mu kuvura kanseri ya ovarian na moneloma nyinshi.
ADCs igizwe na antibody monoclonal ihuriweho nigiti cya cytotoxic. Antibody ihuza cyane cyane kuri Antigen ya Antigen ku kagari ka kanseri, biganisha ku gihugu cya ADC no kurekura ibiyobyabwenge mu Kagari.
Urugero: Adcetris (brentuximib vedotin) Intego CD30, poroteyine iboneka kuri selile zimwe na zimwe za lymphoma, zitanga umukozi wa microtubule.
CPPS ni mugufi aside aside aside ihuza koroshya ibiyobyabwenge cyangwa nanoparticles muri selile. Bashobora guhuzwa nabakozi ba orapeutic cyangwa nanoparticles kugirango bongere imizabibu yabo.
Izi ngamba zirimo kwibasira abakiranutsi bakirwa cyane kuri selile za kanseri. Ligands cyangwa antibodies bihuza kuri aba bakiriye bakoreshwa mugutanga ibiyobyabwenge cyangwa nanoparticles binyuze muri endocytose.
Shandong Baofa Kanseri Ikigo cyubushakashatsi kigira uruhare rugaragara mubushakashatsi no guteza imbere igitabo Igitero cyo gutanga ibiyobyabwenge kuri kanseri sisitemu. Ubushakashatsi bwabo bwibanze kuri twenyine yerekana imyirondoro idasanzwe ya genetike na molecular yabarwayi kugiti cyabo, bugamije kuzamura umusaruro wavuwe no kugabanya ingaruka mbi.
Shandong Baofa kanseri Ikigo cyubushakashatsi Ikora hamwe n'ibitaro nk'ibitaro bya Shandong Baofahttps://aomaahospal.com) Gukora ibigeragezo byubuvuzi no guhindura ubushakashatsi mubikorwa mubikorwa bifatika.
Igitero cyo gutanga ibiyobyabwenge kuri kanseri itanga ibyiza byinshi kuri chimiotherapi isanzwe:
Nubwo wasezeranije, Igitero cyo gutanga ibiyobyabwenge kuri kanseri ahura n'ibibazo byinshi:
Byinshi Igitero cyo gutanga ibiyobyabwenge kuri kanseri Kugeza ubu sisitemu yemewe gukoresha ivuriro:
Izina ry'ibiyobyabwenge | Intego | Ubwoko bwa Kanseri | Uburyo bwo gutanga |
---|---|---|---|
Doxil (Liposoal Doxorubicic) | Intego ya pasiporo binyuze muri EPR Ingaruka | Kanseri ya Ovarian, Myeloma nyinshi | Liposomes |
Adcetris (brentuximab vedotin) | CD30 | Hodgkin Lymphoma, Anaplasti nini ya lymphoma | Antibody-ibiyobyabwenge bihuza (ADC) |
Kadcyla (Trastuzumab Emtine) | We2 | Kanseri ye y'amabere | Antibody-ibiyobyabwenge bihuza (ADC) |
Umurima wa Igitero cyo gutanga ibiyobyabwenge kuri kanseri irahinduka vuba. Ubushakashatsi bw'eyozi azibandaho:
Igitero cyo gutanga ibiyobyabwenge kuri kanseri ifite amasezerano adasanzwe yo kuzamura imiti ya kanseri no kwihangana. Nkuko ubushakashatsi bukomeje, turashobora kwitega kubona neza kandi byihariye Igitero cyo gutanga ibiyobyabwenge kuri kanseri Ingamba ziragaragara, amaherezo ziganisha ku biro byiza bya kanseri.